MA360i helps diagnostic labs get paid for MRD approaches.
Public source
Publisher name
Public post
MRD is becoming a strategic land grab. But buying the assay doesn’t buy the moat. Abbott acquired Exact Sciences. Roche acquired SAGA Diagnostics. Tempus agreed to acqui…
Company
MA360i
Insights that power market access strategy
- Industry
- Information Services
- Location
- San Carlos, US
- Company size
- 2–10 employees
About MA360i
Market Access 360 Insights (MA360i) is transforming diagnostics commercialization and market access by empowering innovative diagnostic labs to get paid for their breakthroughs with AI tools.
See moreLatest activity
Latest activity from MA360i
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Customers & Market
Guardant Health
Guardant Health is leading the way to make colon cancer screening more accessible to more patients.
Customers & Market
N-Power Medicine, Inc.
N-Power Medicine, Inc. is launching colorectal and prostate Prospective External Control Arms programs later this year.
Products & Services
mdxhealth
mdxhealth supports prostate cancer care with diagnostic insights designed to guide care at key decision points along the prostate cancer journey.
Customers & Market
Lighthouse Lab Services
Lighthouse Lab Services worked directly with a payer on MUE edits for CPT 88305.
Products & Services
CancerIQ